Bupropion SR in the naturalistic treatment of elderly patients with major depression

International Journal of Geriatric Psychiatry

Volumn 16, Issue 9, 2001, Pages 862-865

  Steffens, David C ^a   Doraiswamy, P Murali ^a   McQuoid, Douglas R ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antidepressant; Bupropion; Depression; Elderly

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL OBSERVATION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG RESPONSE; ELDERLY CARE; FEMALE; GASTROINTESTINAL SYMPTOM; GERIATRIC DISORDER; HUMAN; MALE; MENTAL HOSPITAL; MONOTHERAPY; PRESCRIPTION; RATING SCALE; REMISSION; SEXUAL DYSFUNCTION; STATISTICAL ANALYSIS; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION;

ADMINISTRATION, ORAL; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; COMORBIDITY; DELAYED-ACTION PREPARATIONS; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GERIATRIC PSYCHIATRY; HUMANS; MALE; TREATMENT OUTCOME;

EID: 0034808833     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.424     Document Type: Article

References (22)

1. Bupropion: A review of its mechanism of antidepressant activity
2. The epidemiology of depression in an elderly community population
3. The prevalence of psychiatric morbidity among people age 85 and over living at home. Associations with reported somatic symptoms and with consulting behaviour
4. Range of mental illness among the elderly in the community. Prevalence in Liverpool using the GMS-AGECAT package
5. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline
6. Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older
7. Prevalence and correlates of depression in a population of nonagenarians
8. Antidepressant use over time in a rural older adult population: The MoVIES project
9. Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients
10. Depressive symptoms in the very elderly. Their prevalence and significance
11. Treatment of chronic depression with sertraline or imipramine: Preliminary blinded response rates and high rates of undertreatment in the community
12. The cardiovascular effects of bupropion and nortriptyline in depressed outpatients
13. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice
14. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction
15. Cumulative illness rating scale
16. The Gospel Oak study: Prevalence rates of dementia, depression and activity limitation among elderly residents in inner London
17. A new depression scale designed to be sensitive to change
18. Augmentation strategies with serotonergic-noradrenergic combinations
19. The epidemiology of affective disorders in the elderly: A review
20. Debate resolved: There are differential effects of serotonin selective reuptake inhibitors on cytochrome P450 enzymes
21. A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group
22. Diagnosis and treatment of depression in late life